(Q38474705)

English

Abnormal expression of four novel molecular markers represents a highly aggressive phenotype in breast cancer. Immunohistochemical assay of p53, nm23, erbB-2, and cathepsin D protein

scientific article published on May 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Abnormal expression of four novel molecular markers represents a highly aggressive phenotype in breast cancer. Immunohistochemical assay of p53, nm23, erbB-2, and cathepsin D protein (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

immunohistochemistry

1 reference

based on heuristic

inferred from title

author name string

Han S

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Yun IJ

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Noh DY

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Choe KJ

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Song SY

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Chi JG

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

publication date

1 May 1997

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Journal of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

22-27

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Progesterone receptors as a prognostic factor in Stage II breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Integration of risk factors to allow patient selection for adjuvant systemic therapy in lymph node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

p53 function and dysfunction

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Mutations in human breast cancer: an overview

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Estrogen receptor, c-erbB-2 and nm23/NDP kinase expression in the intraductal and invasive components of human breast cancers

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

How to use prognostic factors in axillary node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Estradiol Down-Regulates the Mannose-6-Phosphate/Insulin-Like Growth Factor-II Receptor Gene and Induces Cathepsin-D in Breast Cancer Cells: A Receptor Saturation Mechanism to Increase the Secretion of Lysosomal Proenzymes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Implications of the p53 tumor-suppressor gene in clinical oncology.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Telling changes of base

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Steroid receptors, cellular kinetics, and lymph node status as prognostic factors in breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Evidence for a novel gene associated with low tumor metastatic potential

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Nucleoside diphosphate kinase/NM23 expression in breast cancer: lack of correlation with lymph-node metastasis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Nm23 protein expression in ductal in situ and invasive human breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199705%2965%3A1%3C22%3A%3AAID-JSO5%3E3.0.CO%3B2-Q

21 January 2018

Identifiers

10.1002/(SICI)1096-9098(199705)65:1<22::AID-JSO5>3.0.CO;2-Q

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38474705&oldid=2166055768"